Skip to main content
Top
Published in: European Archives of Oto-Rhino-Laryngology 9/2011

Open Access 01-09-2011 | Head and Neck

The cadherin–catenin complex in nasopharyngeal carcinoma

Authors: H. Galera-Ruiz, M. J. Ríos, R. González-Cámpora, M. de Miguel, M. I. Carmona, A. M. Moreno, Hugo Galera-Davidson

Published in: European Archives of Oto-Rhino-Laryngology | Issue 9/2011

Login to get access

Abstract

Abnormal Wnt signaling and impaired cell–cell adhesion due to abnormal E-cadherin and β-catenin function have been implicated in many cancers, but have not been fully explored in nasopharyngeal carcinoma. The aim of this study was to analyze β-Catenin cellular location and E-cadherin expression levels in nasopharyngeal carcinoma. E-cadherin expression levels were also correlated with clinical data and underlying pathology. β-Catenin and E-cadherin expression were examined in 18 nasopharyngeal carcinoma and 7 non-tumoral inflammatory pharynx tissues using immunohistochemical methods. Patient clinical data were collected, and histological evaluation was performed by hematoxylin/eosin staining. β-catenin was detected in membrane and cytoplasm in all cases of nasopharyngeal carcinoma, regardless of histological type; in non-tumoral tissues, however, β-catenin was observed only in the membrane. As for E-cadherin expression levels, strong staining was observed in most non-tumoral tissues, but staining was only moderate in nasopharyngeal carcinoma tissues. E-cadherin expression was associated with β-catenin localization, study group, metastatic disease, and patient outcomes. Reduced levels of E-cadherin protein observed in nasopharyngeal carinoma may play an important role in invasion and metastasis. Cytoplasmic β-catenin in nasopharyngeal carcinoma may impair cell–cell adhesion, promoting invasive behavior and a metastatic tumor phenotype.
Literature
1.
2.
3.
go back to reference Marks JE, Phillips JL, Menck HR (1998) The National Cancer Data Base report on the relationship of race and national origin to the histology of nasopharyngeal carcinoma. Cancer 83:582–588PubMedCrossRef Marks JE, Phillips JL, Menck HR (1998) The National Cancer Data Base report on the relationship of race and national origin to the histology of nasopharyngeal carcinoma. Cancer 83:582–588PubMedCrossRef
5.
go back to reference Mc Crea PD, Gumbiner BM (1991) Purification of a 92-kDa cytoplasmic protein tightly associated with the cell–cell adhesion molecule E-cadherin (uvomorulin). J Biol Chem 266:1359–1361 Mc Crea PD, Gumbiner BM (1991) Purification of a 92-kDa cytoplasmic protein tightly associated with the cell–cell adhesion molecule E-cadherin (uvomorulin). J Biol Chem 266:1359–1361
6.
go back to reference Mazieres J, He B, You L, Xu Z, Jablons D (2005) Wnt signalling in lung cancer. Cancer Lett 222:1–10PubMedCrossRef Mazieres J, He B, You L, Xu Z, Jablons D (2005) Wnt signalling in lung cancer. Cancer Lett 222:1–10PubMedCrossRef
7.
go back to reference Morrison J, Gulley M, Pathmanathan R, Raab-Traub N (2004) Differential signaling pathways are activated in the Epstein–Barr virus-associated malignancies nasopharyngeal carcinoma and Hodgkin lymphoma. Cancer Res 64:5251–5260PubMedCrossRef Morrison J, Gulley M, Pathmanathan R, Raab-Traub N (2004) Differential signaling pathways are activated in the Epstein–Barr virus-associated malignancies nasopharyngeal carcinoma and Hodgkin lymphoma. Cancer Res 64:5251–5260PubMedCrossRef
8.
go back to reference Zeng ZY, Zhou YH, Zhang WL et al (2007) Gene expression profiling of nasopharyngeal carcinoma reveals abnormally regulated Wnt signalling pathway. Human Pathol 38:120–133CrossRef Zeng ZY, Zhou YH, Zhang WL et al (2007) Gene expression profiling of nasopharyngeal carcinoma reveals abnormally regulated Wnt signalling pathway. Human Pathol 38:120–133CrossRef
9.
go back to reference Hoteiya T, Hayashi E, Satomura K et al (1999) Expression of E-cadherin in oral cancer cell lines and its relationship to invasiveness in SCID mice in vivo. J Oral Pathol Med 28:107–111PubMedCrossRef Hoteiya T, Hayashi E, Satomura K et al (1999) Expression of E-cadherin in oral cancer cell lines and its relationship to invasiveness in SCID mice in vivo. J Oral Pathol Med 28:107–111PubMedCrossRef
10.
go back to reference Garcia del Muro X, Torregrosa A, Munoz J et al (2000) Prognostic value of the expression of E-cadherin and beta-cateninin bladder cancer. Eur J Cancer 36:357–362PubMedCrossRef Garcia del Muro X, Torregrosa A, Munoz J et al (2000) Prognostic value of the expression of E-cadherin and beta-cateninin bladder cancer. Eur J Cancer 36:357–362PubMedCrossRef
11.
go back to reference Kim HC, Kim HJ, Kim JC (2002) Reduced E-cadherin expression as a cause of distinctive signet-ring cell variant in colorectal carcinoma. J Korean Med Sci 17:23–28PubMed Kim HC, Kim HJ, Kim JC (2002) Reduced E-cadherin expression as a cause of distinctive signet-ring cell variant in colorectal carcinoma. J Korean Med Sci 17:23–28PubMed
12.
go back to reference Zheng Z, Pan J, Chu B, Wong YC et al (1999) Downregulation and abnormal expression of E-cadherin and beta-catenin in nasopharyngeal carcinoma: close association with advanced disease stage and lymph node metastasis. Hum Pathol 130:458–466CrossRef Zheng Z, Pan J, Chu B, Wong YC et al (1999) Downregulation and abnormal expression of E-cadherin and beta-catenin in nasopharyngeal carcinoma: close association with advanced disease stage and lymph node metastasis. Hum Pathol 130:458–466CrossRef
13.
go back to reference Rubinfeld B, Robbins P, El-Gamil M, Albert I, Porfiri E, Polakis P (1997) Stabilization of beta-catenin by genetic defects in melanoma cell lines. Science 275:1790–1792PubMedCrossRef Rubinfeld B, Robbins P, El-Gamil M, Albert I, Porfiri E, Polakis P (1997) Stabilization of beta-catenin by genetic defects in melanoma cell lines. Science 275:1790–1792PubMedCrossRef
14.
go back to reference Osterheld MC, Bian YS, Bosman FT, Benhattar J, Fontolliet C (2002) Beta-catenin expression and its association with prognostic factors in adenocarcinoma developed in Barrett esophagus. Am J Clin Pathol 117:451–456PubMedCrossRef Osterheld MC, Bian YS, Bosman FT, Benhattar J, Fontolliet C (2002) Beta-catenin expression and its association with prognostic factors in adenocarcinoma developed in Barrett esophagus. Am J Clin Pathol 117:451–456PubMedCrossRef
15.
go back to reference Sugio K, Kase S, Sakada T, Yamazaki K, Yamaguchi M, Ondo K et al (2002) Micrometastasis in the bone marrow of patients with lung cancer associated with a reduced expression of E-cadherin and beta-catenin: risk assessment by immunohistochemistry. Surgery 131:226–231CrossRef Sugio K, Kase S, Sakada T, Yamazaki K, Yamaguchi M, Ondo K et al (2002) Micrometastasis in the bone marrow of patients with lung cancer associated with a reduced expression of E-cadherin and beta-catenin: risk assessment by immunohistochemistry. Surgery 131:226–231CrossRef
16.
go back to reference Perl AK, Wilgenbus P, Dahl U, Semb H, Christofori G (1998) A causal role for E-cadherin in the transition from adenoma to carcinoma. Nature 12:190–193 Perl AK, Wilgenbus P, Dahl U, Semb H, Christofori G (1998) A causal role for E-cadherin in the transition from adenoma to carcinoma. Nature 12:190–193
17.
go back to reference Montgomery E, Torbenson MS, Kaushal M, Fisher C, Abraham SC (2002) Beta-catenin immunohistochemistry separates mesenteric fibromatosis from gastrointestinal stromal tumor and sclerosing mesenteritis. Am J Surg Pathol 26:1296–1301PubMedCrossRef Montgomery E, Torbenson MS, Kaushal M, Fisher C, Abraham SC (2002) Beta-catenin immunohistochemistry separates mesenteric fibromatosis from gastrointestinal stromal tumor and sclerosing mesenteritis. Am J Surg Pathol 26:1296–1301PubMedCrossRef
18.
go back to reference Chou Josephine, Lin Yun-Ching, Kim Jae, You Liang, Zhidong Xu, Biao He, Jablons David M (2008) Nasopharyngeal carcinoma–review of the molecular mechanism of tumorogénesis. Head Neck 230(7):946–963CrossRef Chou Josephine, Lin Yun-Ching, Kim Jae, You Liang, Zhidong Xu, Biao He, Jablons David M (2008) Nasopharyngeal carcinoma–review of the molecular mechanism of tumorogénesis. Head Neck 230(7):946–963CrossRef
19.
go back to reference Jou T, Stewart D, Stappert J, Nelson W, Marrs J (1995) Genetic and biochemical dissection of protein linkages in the cadherin–catenin complex. Proc Natl Acad Sci USA 92:5067–5071PubMedCrossRef Jou T, Stewart D, Stappert J, Nelson W, Marrs J (1995) Genetic and biochemical dissection of protein linkages in the cadherin–catenin complex. Proc Natl Acad Sci USA 92:5067–5071PubMedCrossRef
20.
go back to reference Fandi A, Altun M, Azli N et al (1994) Nasopharyngeal cancer: epidemiology, staging, and treatment. Semin Oncol 21:382–397PubMed Fandi A, Altun M, Azli N et al (1994) Nasopharyngeal cancer: epidemiology, staging, and treatment. Semin Oncol 21:382–397PubMed
21.
go back to reference Horikawa T, Yoshizaki T, Shen TS et al (2000) Association of latent membrane protein 1 and matrix metalloproteinase 9 with metastasis in nasopharyngeal carcinoma. Cancer 89:715–723PubMedCrossRef Horikawa T, Yoshizaki T, Shen TS et al (2000) Association of latent membrane protein 1 and matrix metalloproteinase 9 with metastasis in nasopharyngeal carcinoma. Cancer 89:715–723PubMedCrossRef
22.
go back to reference Lim SC, Lee MS (2002) Significance of E-cadherin/beta-catenin complex and cyclin D1 in breast cancer. Oncol Rep 9:915–928PubMed Lim SC, Lee MS (2002) Significance of E-cadherin/beta-catenin complex and cyclin D1 in breast cancer. Oncol Rep 9:915–928PubMed
23.
go back to reference Clements WM, Wang J, Sarnaik A et al (2002) Beta-catenin mutation is a frequent cause of Wnt pathway activation in gastric cancer. Cancer Res 62:3503–3506PubMed Clements WM, Wang J, Sarnaik A et al (2002) Beta-catenin mutation is a frequent cause of Wnt pathway activation in gastric cancer. Cancer Res 62:3503–3506PubMed
24.
go back to reference Gumbiner BM (1997) Carcinogenesis: a balance between betactenin and APC. Curr Biol 7:443–446CrossRef Gumbiner BM (1997) Carcinogenesis: a balance between betactenin and APC. Curr Biol 7:443–446CrossRef
25.
go back to reference Joo YE, Rew JS, Choi SK et al (2002) Expression of E-cadherin and catenins in early gastric cancer. J Clin Gastroenterol 35:35–42PubMedCrossRef Joo YE, Rew JS, Choi SK et al (2002) Expression of E-cadherin and catenins in early gastric cancer. J Clin Gastroenterol 35:35–42PubMedCrossRef
26.
go back to reference Kallakury BV, Sheehan CE, Winn-Deen E et al (2001) Decreased expression of catenin (alpha and beta), p120 CTN, and E-cadherin cell adhesion proteins and E-cadherin gene promoter methylation in prostatic adenocarcinomas. Cancer 92:2786–2795PubMedCrossRef Kallakury BV, Sheehan CE, Winn-Deen E et al (2001) Decreased expression of catenin (alpha and beta), p120 CTN, and E-cadherin cell adhesion proteins and E-cadherin gene promoter methylation in prostatic adenocarcinomas. Cancer 92:2786–2795PubMedCrossRef
27.
go back to reference Li Z, Lin SX, Liang YJ (2003) Influence of E-cadherin promoter methylation and mutation of beta-catenin on invasion and metastasis of nasopharyngeal carcinoma cells. Zhonghua Zhong Liu Za Zhi 25(3):238–242PubMed Li Z, Lin SX, Liang YJ (2003) Influence of E-cadherin promoter methylation and mutation of beta-catenin on invasion and metastasis of nasopharyngeal carcinoma cells. Zhonghua Zhong Liu Za Zhi 25(3):238–242PubMed
28.
go back to reference Zhi Li, Ren Yi, Su-xia Lin, Ying-jie Liang, Hui-Zhen Liang (2004) Association of E-cadherin and β-catenin with metastasis in nasopharyngeal carcinoma. Chin Med J 117(8):1232–1239 Zhi Li, Ren Yi, Su-xia Lin, Ying-jie Liang, Hui-Zhen Liang (2004) Association of E-cadherin and β-catenin with metastasis in nasopharyngeal carcinoma. Chin Med J 117(8):1232–1239
29.
go back to reference Dogan A, Wang ZD, Spencer J (1995) E-cadherin expression in intestinal epithelium. J Clin Pathol 48:143–146PubMedCrossRef Dogan A, Wang ZD, Spencer J (1995) E-cadherin expression in intestinal epithelium. J Clin Pathol 48:143–146PubMedCrossRef
30.
go back to reference Hajra KM, Fearon ER (2002) Cadherin and catenin alterations in human cancer. Genes Chromosomes Cancer 34:255–268PubMedCrossRef Hajra KM, Fearon ER (2002) Cadherin and catenin alterations in human cancer. Genes Chromosomes Cancer 34:255–268PubMedCrossRef
31.
go back to reference Takeichi M (1993) Cadherins in cancer: implications for invasion and metastasis. Curr Opin Cell Biol 5:806–811PubMedCrossRef Takeichi M (1993) Cadherins in cancer: implications for invasion and metastasis. Curr Opin Cell Biol 5:806–811PubMedCrossRef
32.
go back to reference Chow V, Yuen APW, Lam KY et al (2001) A comparative study of the clinicopathological significance of E-cadherin and catenins (α, β, γ) expression in the surgical management of oral tongue carcinoma. J Cancer Res Clin Oncol 127:59–63PubMedCrossRef Chow V, Yuen APW, Lam KY et al (2001) A comparative study of the clinicopathological significance of E-cadherin and catenins (α, β, γ) expression in the surgical management of oral tongue carcinoma. J Cancer Res Clin Oncol 127:59–63PubMedCrossRef
33.
go back to reference Mattijssen V, Peters HM, Schalkwijk L et al (1993) E-cadherin expression in head and neck squamous-cell carcinoma is associated with clinical outcome. Int J Cancer 55:580–585PubMedCrossRef Mattijssen V, Peters HM, Schalkwijk L et al (1993) E-cadherin expression in head and neck squamous-cell carcinoma is associated with clinical outcome. Int J Cancer 55:580–585PubMedCrossRef
34.
go back to reference Franchi A, Gallo O, Boddi V et al (1996) Prediction of occult neck metastases in laryngeal carcinoma: role of proliferating cell nuclear antigen, MIB-1, and E-cadherin immunohistochemical determination. Clin Cancer Res 2:1801–1808PubMed Franchi A, Gallo O, Boddi V et al (1996) Prediction of occult neck metastases in laryngeal carcinoma: role of proliferating cell nuclear antigen, MIB-1, and E-cadherin immunohistochemical determination. Clin Cancer Res 2:1801–1808PubMed
35.
go back to reference Rodrigo JP, Dominguez F, Alvarez C et al (2002) Expression of E-cadherin in squamous cell carcinomas of the supraglottic larynx with correlations to clinicopathological features. Eur J Cancer 38:1059–1064PubMedCrossRef Rodrigo JP, Dominguez F, Alvarez C et al (2002) Expression of E-cadherin in squamous cell carcinomas of the supraglottic larynx with correlations to clinicopathological features. Eur J Cancer 38:1059–1064PubMedCrossRef
36.
go back to reference Takes RP, Baatenburg de Jong RJ, Alles MJRC et al (2002) Markers for nodal metastasis in head and neck squamous cell cancer. Arch Otolaryngol Head Neck Surg 128:512–518PubMed Takes RP, Baatenburg de Jong RJ, Alles MJRC et al (2002) Markers for nodal metastasis in head and neck squamous cell cancer. Arch Otolaryngol Head Neck Surg 128:512–518PubMed
37.
go back to reference Andrews NA, Jones AS, Helliwell TR et al (1997) Expression of the E-cadherin–catenin cell adhesion complex in primary squamous cell carcinomas of the head and neck and their nodal metastases. Br J Cancer 75:1474–1480PubMedCrossRef Andrews NA, Jones AS, Helliwell TR et al (1997) Expression of the E-cadherin–catenin cell adhesion complex in primary squamous cell carcinomas of the head and neck and their nodal metastases. Br J Cancer 75:1474–1480PubMedCrossRef
38.
go back to reference Beavon IRG (2000) The E-cadherin–catenin complex in tumour metastasis: structure, function and regulation. Eur J Cancer 36:1607–1620PubMedCrossRef Beavon IRG (2000) The E-cadherin–catenin complex in tumour metastasis: structure, function and regulation. Eur J Cancer 36:1607–1620PubMedCrossRef
Metadata
Title
The cadherin–catenin complex in nasopharyngeal carcinoma
Authors
H. Galera-Ruiz
M. J. Ríos
R. González-Cámpora
M. de Miguel
M. I. Carmona
A. M. Moreno
Hugo Galera-Davidson
Publication date
01-09-2011
Publisher
Springer-Verlag
Published in
European Archives of Oto-Rhino-Laryngology / Issue 9/2011
Print ISSN: 0937-4477
Electronic ISSN: 1434-4726
DOI
https://doi.org/10.1007/s00405-010-1464-z

Other articles of this Issue 9/2011

European Archives of Oto-Rhino-Laryngology 9/2011 Go to the issue